Skip to main content
. 2007 Mar 8;7:7. doi: 10.1186/1472-6947-7-7

Table 3.

Completeness of Databases

Completeness Score CP EP FC LC MM EF RL
Dosage/Schedule 2.88 2.92 2.93 2.92 3.00 2.92 3.00
Drug Interactions 2.93 2.69 2.79 2.77 3.00 2.67 2.42
Methods of Administration 2.92 2.67 2.92 3.00 2.92 2.60 2.58
Adverse Drug Reactions 2.69 2.89 2.92 2.92 3.00 2.89 2.40
Over-the-Counter 2.73 2.75 2.64 2.89 2.17 2.75 2.33
Indications/Unlabeled Uses 3.00 2.67 3.00 3.00 3.00 2.67 3.00
Identification/Content 2.90 2.86 2.88 2.89 2.88 2.80 2.88
Pharmacokinetics 2.88 2.60 2.89 2.63 2.67 3.00 2.50
Compatibility/Stability 2.88 2.75 2.83 2.89 3.00 3.00 2.67
Contraindications 3.00 3.00 3.00 2.86 2.89 3.00 2.75
Dietary Supplements 3.00 2.86 2.88 2.33 3.00 NA 2.80
Pharmacology/MOA 2.88 2.71 3.00 2.63 3.00 2.71 3.00
Pregnancy and Lactation 3.00 2.83 3.00 3.00 2.88 2.83 2.63
Foreign Drug Identification 3.00 NA 1.00 3.00 3.00 NA NA
Cost and Economics 3.00 3.00 3.00 3.00 NA 3.00 3.00
(%) 96.4 93.2 95.8 95.2 97.0 93.2 89.6

CP = Clinical Pharmacology, EP = Epocrates Premium, FC = Facts & Comparisons 4.0, LC = Lexi-Comp Online, MM = Micromedex, EF = Epocrates Free, RL = RxList, NA = no score/no answer present